Nosopharm renews its partnership with Inra
Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest
Les sept pôles de compétitivité en santé français se constituent en réseau
NovAliX’ clients can now access Pierre Fabre’s library of original fragments isolated from plants
Antibiotic resistance: Nosopharm and the University of Illinois at Chicago in Molecular Cell
NovAliX enters into cooperation agreement with Max-Planck spin-off
Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All™ technology
Noventure and Laboratorios Salvat enter into agreement to commercialise innovative medical device in Spain and Portugal for rhinitis and rhinosinusitis
